Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Blood Cancer Drugs Market Through 2034?

Recent years have witnessed significant growth in the size of the blood cancer drugs market. The market, valued at $74.69 billion in 2024, is projected to grow to $79.6 billion in 2025, representing a compound annual growth rate (CAGR) of 6.6%. Factors contributing to the growth observed during the historic period include progress in research and development, an ageing population, heightened awareness and early detection, and regulatory approvals.

The market size of drugs for blood cancer is predicted to experience robust growth in the forthcoming years. The market is projected to escalate to $104.37 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. Factors contributing to the growth in the projected period include rising disease incidence, emerging markets, and supportive care. Dominant trends during the forecast period encompass investment in research and development, combined therapies, biomarker detection, advancements in immunotherapy, and individualized medicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2587&type=smp

What are the Fundamental Drivers and Innovations Shaping the Blood Cancer Drugs Market?

The increasing occurrence and death rates from blood cancer worldwide are propelling the growth of the blood cancer drugs market. There are various forms of blood cancer, including lymphoma, leukemia, myeloma, etc., each having unique risk factors. Some of these risks can be mitigated or avoided through medications, while others may result in death. For example, a report from Bristol-Myers Squibb Company in November 2022 highlighted that an estimated 1.85 million new blood cancer cases are anticipated worldwide in 2040. These include 918,872 lymphoma cases, 656,345 leukemia cases, and 275,047 myeloma cases. Moreover, the report predicts that there will be approximately 1,100,000 deaths due to blood cancer in 2040. The escalating death toll and the rising global incidence of blood cancer cases are key factors driving the growth of the blood cancer drugs market.

How Is the Blood Cancer Drugs Market Segmented?

The blood cancer drugs market covered in this report is segmented –

1) By Blood Cancer Type: Leukemia, Lymphoma

2) By Drugs: Rituxan Or Mabthera (Rituximab), Gleevec Or Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs

3) By Treatment Approaches: Key Findings, Chemotherapeutic, MAbs/Targeted Therapies, Immunotherapeutic

Subsegments:

1) By Leukemia: Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Other Types of Leukemia

2) By Lymphoma: Hodgkin Lymphoma, Non-Hodgkin Lymphoma (NHL), Burkitt Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Other Types of Lymphoma

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2587&type=smp

Which Regions Are Driving the Next Phase of the Blood Cancer Drugs Market Growth?

North America was the largest region in the blood cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the blood cancer drugs market during the forecast period. The regions covered in the blood cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Blood Cancer Drugs Market?

Leading firms in the blood cancer drugs market are concentrating on the innovation of new medications and striving for FDA approval to achieve a competitive advantage. FDA approval for medications denotes the official permission given by the United States Food and Drug Administration (FDA) for a drug product to be legally marketed in the United States. For example, Bristol Myers Squibb, a company based in the US pharmaceutical sector, acquired FDA approval for its exclusive CAR T-cell therapy for adults with recurring or resistant chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in March 2024. This fast-tracked approval permits its usage in patients who have undergone at least two previous treatments, such as a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. The TRANSCEND CLL 004 trial revealed a 20% full response rate and a median response duration of 35.3 months among responders for Breyanzi.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

How Is the Blood Cancer Drugs Market Defined and What Are Its Core Parameters?

Blood Cancer Drugs Blood cancer drugs refer to the drugs or medications that are used to treat blood cancer drugs by using the body’s immune system to fight blood cancer by slowing down the growth of cancer cells. Chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant are a few of the frequently used blood cancer treatments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2587

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model